Tranexamic acid in patients undergoing noncardiac surgery.
Devereaux PJ, Marucci M, Painter TW, Conen D, Lomivorotov V, Sessler DI et al, for the POISE-3 Investigators.
N Engl J Med 2022; 386: 1986-1997.
A total of 9535 procedures were studied. Tranexamic acid reduced bleeding complications (11.7 versus 9.1 per cent, P<0.001), but slightly increased the risk of cardiovascular complications (14.2 versus 13.9 per cent, P=0.04).
Comment: Is the trade-off worth it, except for specific procedures with high blood loss?
13 July 2022
Read paperAcademy
Part of the charitable activity of the Society, BJS Academy is an online educational resource for current and future surgeons.
The Academy is comprised of five distinct sections: Continuing surgical education, Young BJS, Cutting edge, Scientific surgery and Surgical news. Although the majority of this is open access, additional content is available to BJS subscribers and strategic partners.
